Nuno Afonso has built his career in healthcare innovation for two decades spanning academia and industry in research, biotech, pharmaceuticals and venture capital investments. He has started his career in Life Sciences and Healthcare as a biomedical researcher at the Pitié-Salpetrière Hospital, Paris (2000-2005). He then moved to Portugal in 2005 to lead post-doctoral research at Instituto Gulbenkian de Ciência and Instituto de Medicina Molecular, Portugal (2005-2010). In 2008, Nuno co-founded a biotech business (CNS & Rheumatology; TechnoZeb business, TechnoPhage). Business Unit Manager until 2013 then Corporate Development Director at TechnoPhage, Nuno led end-to- end operations, financing and portfolio diversification globally (2008-2015). In early 2016, Nuno joined the brand teams of Neuroscience and Immunology of Janssen Pharmaceutical Companies of Johnson & Johnson as a Therapeutic Area Leader (2016-2017) among other responsibilities. Nuno then took responsibilities as an Investment Manager at Portugal Ventures since late 2017 while serving as a Director of the Board in numerous companies of its portfolio in therapeutics, medical devices and digital health. In April 2019, Nuno launched HinnovaCare Business Advisory. He is a Business and Board Advisor in Healthcare Innovation working with stakeholders of the sector (healthcare professionals, companies, investors, universities, incubators, public bodies) in strategy, implementation and investment to foster growth and impact in healthcare innovation development and access. Nuno holds an undergraduate degree in Biochemistry (Faculty of Sciences, Lisbon, 2000), a PhD degree in Biomedical Sciences (Université Pierre et Marie Curie, Paris, 2005) and an MBA from The Lisbon MBA (CATOLICA / NOVA, 2012) with which he still collaborates in the alumni network under healthcare sector initiatives.